Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5594
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo ; day:24 ; month:11 ; year:2020 ; pages:1-17
Oncogene ; (24.11.2020), 1-17
- Creator
-
Attalla, Sherif
Taifour, Tarek
Bui, Tung
Muller, William
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41388-020-01560-0
- URN
-
urn:nbn:de:101:1-2021010420190480453730
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Attalla, Sherif
- Taifour, Tarek
- Bui, Tung
- Muller, William
- SpringerLink (Online service)
Other Objects (12)
Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model
PyMT-1099, a versatile murine cell model for EMT in breast cancer
GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer
MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice
Extracellular Proteolysis in Transgenic Mouse Models of Breast Cancer
Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer
Breast cancer
Breast cancer
Breast cancer
Canonical NF-κB signaling in myeloid cells promotes lung metastasis in the PyMT breast cancer model
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer
CYP17genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study
Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model
PyMT-1099, a versatile murine cell model for EMT in breast cancer
GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer
MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice
Extracellular Proteolysis in Transgenic Mouse Models of Breast Cancer
Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer
Breast cancer
Breast cancer
Breast cancer
Canonical NF-κB signaling in myeloid cells promotes lung metastasis in the PyMT breast cancer model
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer
CYP17genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study
Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model
PyMT-1099, a versatile murine cell model for EMT in breast cancer
GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer
MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice
Extracellular Proteolysis in Transgenic Mouse Models of Breast Cancer
Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer
Breast cancer
Breast cancer
Breast cancer
Canonical NF-κB signaling in myeloid cells promotes lung metastasis in the PyMT breast cancer model
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer